Brad L. Tade is CFO and Treasurer of ADMA BIOLOGICS, INC.. Currently has a direct ownership of 256,380 shares of ADMA, which is worth approximately $5.2 Million. The most recent transaction as insider was on Feb 26, 2025, when has been sold 5,280 shares (Common Stock) at a price of $15.78 per share, resulting in proceeds of $83,318. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 256K
28.55% 3M change
n/a 12M change
Total Value Held $5.2 Million

Brad L. Tade Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 26 2025
SELL
Payment of exercise price or tax liability
$83,318 $15.78 p/Share
5,280 Reduced 2.02%
256,380 Common Stock
Feb 19 2025
BUY
Grant, award, or other acquisition
-
62,227 Added 19.21%
261,660 Common Stock
Nov 22 2024
SELL
Open market or private sale
$317,250 $21.15 p/Share
15,000 Reduced 7.0%
199,433 Common Stock
Jul 24 2024
BUY
Grant, award, or other acquisition
-
72,400 Added 25.24%
214,433 Common Stock
BLT

Brad L. Tade

CFO and Treasurer
Boca Raton, FL

Track Institutional and Insider Activities on ADMA

Follow ADMA BIOLOGICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADMA shares.

Notify only if

Insider Trading

Get notified when an Adma Biologics, Inc. insider buys or sells ADMA shares.

Notify only if

News

Receive news related to ADMA BIOLOGICS, INC.

Track Activities on ADMA